Imagion Biosystems
Follow
Get notifications in MyBN when activity occurs.
Upgrade your subscription to use this feature.
Industry Lists
Public Companies - non WAImagion Biosystems (IBX) is developing a new non-radioactive and safe diagnostic imaging technology.
Combining biotechnology and nanotechnology, the company aims to detect cancer and other diseases earlier and with higher specificity than is currently possible.
Contact Details
Level 25, 525 Collins Street, MELBOURNE VIC 3000
Lists and Charts
Share Price
Closing price for the last 90 trading days
Powered by Morningstar ®
Share Transactions
Total value as at the date of the transaction
Powered by Morningstar ®
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| th |  | Imagion Biosystems | $5.2m |
1330 listed non wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Total Shareholder Return as at 29/02/24
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 1891st | Imagion Biosystems | -90% | -39% |
1790 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Powered by Morningstar ®
Collapse All Lists and Charts
Company Activity
| NEW ROLE: Yalia Jayalakshmi, | 02 Sep 2022 |
| NEW ROLE: Geoff Hollis, Chief Financial Officer, Company Secretary | 21 May 2021 |
| NEW ROLE: Giulio Paciotti, | 24 Nov 2020 |
| NEW ROLE: Brian Conn, Chief Financial Officer | 24 Nov 2020 |
| NEW ROLE: Robert Proulx, Executive Chair, President, Chief Executive | 03 Nov 2020 |
| NEW ROLE: Jovanka Naumoska, Company Secretary, Non-Executive Director | 03 Nov 2020 |
| NEW ROLE: Dianne Angus, Non-Executive Director | 03 Nov 2020 |
| NEW ROLE: Michael Harsh, Non-Executive Director | 03 Nov 2020 |
| NEW ROLE: Mark Van Asten, Non-Executive Director | 03 Nov 2020 |
